A CLINICAL STUDY ON EFFECT OF VASAKADI EYE DROPS AND SHADANGA GUGGULU IN THE MANAGEMENT OF COMPUTER VISION SYNDROME

EVALUATION OF EFFICACY OF VASAKADI EYE DROPS AND SHADANGA GUGGULU IN THE MANAGEMENT OF COMPUTER VISION SYNDROME (CVS) - AN OPEN LABEL DOUBLE ARM RANDOMIZED CONTROL TRIAL - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/077070

Enrollment

Registered

2024-11-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H041- Other disorders of lacrimal gland

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having minimum 3 hours exposure to any type of visual display terminal like desktop laptop mobile etc daily 2. Patients having minimum three symptoms of CVS Shushkakshipaka 3. Pateints wearing spectacles and contact lenses

Exclusion criteria

Exclusion criteria: 1. Patients having other systemic diseases or uncontrolled metabolic disorders such as HTN, DM, thyroid dysfunction and any other illness requiring long term drug treatment 2. Patients suffering from infectious conditions of the eye like conjunctivitis,dry eye syndrome, scleritis, uveitis,glaucoma, stye, etc 3. Any fundus pathology like optic atrophy, diabetic retinopathy, hypertensive Retinopathy, papilledema etc 4. Past history of any surgical intervention to the eye

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptoms of Computer Vision Syndrome Shushkakshipaka i.e. Eye strain, dry eyes and burning eyes. blurred vision, redness, diplopia, irritated eye and slow refocusingTimepoint: Improvement in signs and symptoms of Computer Vision Syndrome Shushkakshipaka i.e. Eye strain, dry eyes and burning eyes. blurred vision, redness, diplopia, irritated eye and slow refocusing i.e.at before treatment,2nd week,4th week,6th week and 10th week	—

Measure

Time frame

Improvement in signs and symptoms of Computer Vision Syndrome Shushkakshipaka i.e. Eye strain, dry eyes and burning eyes. blurred vision, redness, diplopia, irritated eye and slow refocusingTimepoint: Improvement in signs and symptoms of Computer Vision Syndrome Shushkakshipaka i.e. Eye strain, dry eyes and burning eyes. blurred vision, redness, diplopia, irritated eye and slow refocusing i.e.at before treatment,2nd week,4th week,6th week and 10th week

—

Secondary

Measure	Time frame
1. Improvement in other signs & symptoms of Computer Vision Syndrome Shushkakshipaka which includes musculoskeletal symptoms i.e.Headache/Neck pain/Shoulder pain/Backache. 2.The study will provide physicochemical & organoleptic properties of trial drug Timepoint: 1. Improvement in other signs & symptoms of Computer Vision Syndrome Shushkakshipaka which includes musculoskeletal symptoms i.e.Headache/Neck pain/Shoulder pain/Backache.i.e. at before treatment,2nd week,4th week,6th week & 10th week 2.The study will provide physicochemical & organoleptic properties of trial drug	—

Measure

Time frame

1. Improvement in other signs & symptoms of Computer Vision Syndrome Shushkakshipaka which includes musculoskeletal symptoms i.e.Headache/Neck pain/Shoulder pain/Backache. 2.The study will provide physicochemical & organoleptic properties of trial drug Timepoint: 1. Improvement in other signs & symptoms of Computer Vision Syndrome Shushkakshipaka which includes musculoskeletal symptoms i.e.Headache/Neck pain/Shoulder pain/Backache.i.e. at before treatment,2nd week,4th week,6th week & 10th week 2.The study will provide physicochemical & organoleptic properties of trial drug

—

Countries

India

Contacts

Public ContactDrGayatri Sudhakar Patil

All India Institute of Ayurveda,New Delhi

eyenimi@gmail.com9650715615

Outcome results